+
+
Stay Informed
MITRAL REGURGITATION TREATMENT

MITRAL VALVE REPAIR

Treatment for mitral regurgitation, or leaky mitral valve, depends on how severe your condition is, and if it’s getting worse.1 The goal of treatment is to improve your heart’s function while minimizing your symptoms and avoiding future complications.

If you have mitral regurgitation, mitral valve repair surgery is considered one of the most effective long-term treatments. Mitral valve repair gives you the greatest probability for a safe and effective solution over time. 

Options to repair the mitral valve include traditional open-heart surgery and a minimally invasive transcatheter procedure:

Treatment option for Mitral Regurgitation

DISCUSS ALL TREATMENT OPTIONS WITH YOUR DOCTOR
Your doctor can describe the risks and benefits and help you decide which option is right for you.

Medications

MEDICATION


Medications may be prescribed to help manage symptoms of mitral regurgitation, such as diuretics for fluid buildup in the legs and lungs. However, these medications only treat the symptoms and do not address the underlying problem with your mitral valve that is causing your disease.

Mitral Valve Repair Surgery

MITRAL
VALVE REPAIR SURGERY

If mitral valve repair is an option for you, a surgical technique called an annuloplasty may be performed. This procedure typically involves the implantation of a device to tighten or replace the ring around the mitral valve (annulus) so that the valve leaflets can close properly. When needed, other techniques may be used to repair the valve.

 

Transcatheter Edge-to-Edge Repair

TRANSCATHETER
EDGE-TO-EDGE REPAIR (TEER)*

TEER with MitraClip™ therapy is a minimally invasive procedure that may be an option for people with severe mitral regurgitation. Unlike surgery, this procedure does not require chest incisions and temporarily stopping the heart. In this procedure, a small implanted clip is attached to your mitral leaflet (accessed through a vein in your leg) to help it close more completely. This helps to restore normal blood flow through your heart.

*Formerly referred to as transcatheter mitral valve repair (TMVr).

A guide for people with mitral regurgitation

Download the mitral regurgitation treatment guide to learn more about a minimally invasive transcatheter mitral valve repair option

DOWNLOAD GUIDE

Scott

See how patients like Scott benefit from MitraClip™ therapy

Scott was an avid runner all of his life, but his mitral regurgitation had progressed to the point where he could no longer climb the stairs. Watch Scott’s story to learn how minimally invasive MitraClip therapy enabled him to regain his life and start running again.

This testimonial relates an account of an individual’s response to the treatment. This patient’s account is genuine, typical, and documented. However, it does not provide any indication, guide, warranty, or guarantee as to the response other persons may have to the treatment. Responses to the treatment discusses can and do vary and are specific to the individual patient.

Find a Doctor Near Me

Find a clinic that is certified to perform TEER with MitraClip™ therapy.

Show nearest:
Filter by:

The information provided is not intended for medical diagnosis or treatment or as a substitute for professional advice. Consult with a physician or qualified healthcare provider for appropriate medical advice.

MAT-2305138 v3.0 | Item approved for U.S. use only.

References
  1. Heidenreich PA, et al. “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association. Joint Committee on Clinical Practice Guidelines.” J Am Coll Cardiol. Apr 01, 2022. Epublished DOI: 10.1016/j.jacc.2021.12.012.
Important Safety Information
  • MitraCLIP

  • WHAT IS MITRACLIP™ THERAPY APPROVED FOR?
    Available by prescription only.

    MitraClip therapy is a minimally invasive procedure approved for treating patients with clinically significant mitral regurgitation due to either (a) a deteriorated mitral valve in patients who are deemed to be at prohibitive risk for surgery, or (b) mitral valve in patients who have heart failure and an enlarged heart who remain symptomatic on maximally tolerated medications to treat their heart failure.

    Patients should work with their doctor and a multidisciplinary heart team, which should include a heart surgeon and cardiologist with experience treating heart failure, to confirm their surgical risk or optimal medications. The heart team will determine if the patient meets the indications for the MitraClip procedure.

    WHO SHOULD NOT HAVE THE MITRACLIP PROCEDURE?

    Patients that have any of the following conditions should not have the MitraClip Procedure: inability to tolerate or are allergic or hypersensitive to anti coagulants, anti-platelet therapies, nickel, titanium, cobalt, chromium, polyester, or contrast dye; have inflammation or rheumatic disease of the valve; have blood clots inside the heart or blood vessels (inferior vena cava, femoral vein), or have mitral valve anatomy which is deemed not suitable for repair with Mitraclip.

    WHAT CAN HAPPEN TO ME DURING THE MITRACLIP PROCEDURE?

    As with most medical procedures, MitraClip Implant placement has risks, including inappropriate device placement, device movement from its implanted site, and failed or difficult delivery or retrieval of the device once implanted. Your physician will determine if you fall within the labeled indication for the MitraClip Procedure.

    WHO IS MORE AT RISK DURING THE MITRACLIP PROCEDURE?

    Even though MitraClip Therapy is a minimally invasive medical procedure, it carries risks, and some patients may be at a higher risk than others. If you have either a weak heart that may need support during the procedure or a rotated heart from prior heart surgery, talk to your doctor to weigh the additional risks to the benefits of the MitraClip Procedure as the safety and effectiveness has not been tested in these patients.

    WHAT ARE THE POSSIBLE COMPLICATIONS ASSOCIATED WITH THE MITRACLIP PROCEDURE?

    The MitraClip Procedure carries risks which include, but are not limited to: Allergic reactions to the implant materials or medications used during or after the procedure; Tissue damage at the puncture (entry site such as wound reopening, reaction to the catheter, bleeding, air bubbles, tissue or nerve injury; Inflammation, buildup of fluid or blood in the sac surrounding the heart, and complications that may require more interventions or heart surgery; Mitral valve complications including device dislodgement, entanglement with chords, narrowing of the mitral valve, continuing backflow of blood through the mitral valve during heart contraction, and inflammation; Abnormal heart rhythm, stroke (resulting from blood clot or burst vessel in the brain or transient stroke, high or low blood pressure; Multiple organ failure, death, pain; Complications related to the echocardiographic imaging such as irritation or perforation of the throat.

    Talk to your doctor to learn more about the risks associated with MitraClip Therapy, and ask for the detailed Important Safety Information if you'd like to review the full list of complications.

Abbott Logo

Follow Abbott

Copyright © 2024 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
CAUTION: Product(s) intended for use by or under the direction of a physician. Prior to use, reference to the Instructions for Use, inside the product carton (when available) or at https://www.eifu.abbott/ for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2302755 v4.0  |   Item approved for U.S. use only.

+